ACTIVE

DR. GLIBERT NELE NEUROLOGIE

Export PDF

Financial year 2024 · Closed on 31/12/2024

Net result214,5 k €+13,7 %over 1 year
Gross margin325,5 k €+15,5 %over 1 year
Equity216,5 k €+13,5 %over 1 year

Identity

Source · BCE/KBO

DR. GLIBERT NELE NEUROLOGIE is a Private limited company incorporated in 2020. Its main activity is: Specialist medical practice activities. Its registered office is in Izegem.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0758.468.833
Incorporation
16/11/2020
Legal form
Private limited company
Registered office
Kokelarestraat 46
8870 Izegem · FlandreSee on map
Contributed capital
2 000,00 €
Latest accounts
31/12/2024
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 5 filings

Trend over 5 financial years

20242023202220212020
Income statement
Gross margin325,5 k €281,8 k €265,1 k €341,2 k €91,3 k €
EBITDA325,3 k €281,6 k €264,9 k €340,9 k €91,2 k €
Operating result298,4 k €254,7 k €241,9 k €318,6 k €87,6 k €
Net result214,5 k €188,7 k €181,9 k €242,3 k €69,6 k €
Balance sheet
Equity216,5 k €190,7 k €495,7 k €313,9 k €71,6 k €
Total assets455,4 k €435,3 k €577,1 k €519,1 k €234,2 k €
Cash147,7 k €101,1 k €248,9 k €210,5 k €17,9 k €
Debts220 k €237,7 k €76,7 k €193,9 k €162,6 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2024

1 active

Active mandates

Nele Glibert

Director

Active

Other companies at this address

Kokelarestraat 46 8870 Izegem
CompanyCBE no.
AHS● Active
0733.591.895
AHS Invest● Active
0725.704.312
Maneas● Active
0725.471.611

Full financial information

Source · NBB
20242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202401/01/202301/01/202201/01/202116/11/2020
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months2 months
Filing date30/09/202525/09/202428/08/202327/09/202231/08/2021
General meeting21/06/202515/06/202417/06/202318/06/202219/06/2021
Currency of the financial yearEUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 5 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202421/06/202530/09/2025DutchPDF
Micro model31/12/202315/06/202425/09/2024DutchPDF
Micro model31/12/202217/06/202328/08/2023DutchPDF
Micro model31/12/202118/06/202227/09/2022DutchPDF
Micro model31/12/202019/06/202131/08/2021DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

1 active

Active mandates

Nele Glibert

Director

Active

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other18/11/2020
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024214,5 k €↑
  2. 2023
    Annual accounts 2023188,7 k €↑
  3. 2022
    Annual accounts 2022181,9 k €↓
  4. 2021
    Annual accounts 2021242,3 k €↑
  5. 2020
    Annual accounts 202069,6 k €
  6. 16/11/2020
    IncorporationPrivate limited company